Pulse Protocol

Early Stage

Medical Travel Platform for Hospitals & Doctors


Raised to Date: Raised: $123,888

Aggregate Commitments $



Start Date


Close Date


Min. Goal


Max. Goal


Min. Investment


Security Type

Equity - Common

Funding Type




Pre-Money Valuation


Rolling Commitments $



Reporting Date


Days Remaining


% of Min. Goal


% of Max. Goal


Likelihood of Max
Avg. Daily Raise


Log in or create a free account today to gain access to KingsCrowd analytics.

Venice, California


Business Services, Software, & Applications

Tech Sector


Distribution Model




Capital Intensity


Business Type


Pulse Protocol, with a pre-money valuation of $6.15 million, is raising funds on StartEngine. The company has developed a software and marketing platform for doctors and healthcare professionals to manage their medical travel businesses. The medical travel SaaS platform connects patients and providers across borders, improves the patient experience, and increases productivity. Robert Page founded Pulse Protocol in April 2015. The current crowdfunding round has a minimum target of $10,000 and a maximum target of $1,069,999.75. The funds will be used for the implementation of the software beyond the original niche of the medical travel business. Pulse Protocol works on an efficient business model, earning revenue through licensing the software, providing marketing services, and charging transaction fees.

Summary Profit and Loss Statement

Most Recent Year Prior Year












Net Income



Summary Balance Sheet

Most Recent Year Prior Year




Accounts Receivable



Total Assets



Short-Term Debt



Long-Term Debt



Total Liabilities



Financials as of: 05/25/2021
Log in or create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)


$8.33 /month
billed annually
Free portfolio tracking. Limited reports and filters.
Plan Includes:
Everything in Free, plus
Advanced company search ( limited filters)
Founder profiles and exclusive webinars
2 Analyst Reports per month
Get Starter Annual


$25 /month
billed annually
Unlimited analyst reports and market analytics.
Plan Includes:
Everything in Starter, plus
Full access to all Analyst Reports
Filter on Staff Picks (e.g. Top Deal, Deal to Watch, etc.)
Market Analytics
Get Pro Annual


$41.67 /month
billed annually
Full site access including Merlin ratings.
Plan Includes:
Everything in Pro, plus
Search and filter companies by Merlin ratings
Company specific Merlin rating and risk assessment
Get Merlin Annual
Already a member? Log in here.


Analyst Report


The relentless pace of globalization has created a phenomenon of medical tourism. Medical tourists are patients who travel outside of their home country to treat a medical problem, whether for legal, technological, or financial reasons. Medical tourists visiting South Korea, for example, can access high-quality healthcare at a significantly cheaper rate than they can in the US, Japan, and Germany. In 2017, more than 1.4 million Americans traveled outside the country in search of medical care, as did between 14 million and 16 million patients worldwide.

Despite its popularity, medical tourism is plagued with a number of challenges. Simply put, patients need to find the right doctors, and doctors need to find the right patients. There is limited existing infrastructure to support this kind of screening in foreign countries (not to mention language barriers), so patients often need to adapt as they go.

Pulse Protocol helps patients and providers find each other across borders. The service is a software and marketing platform that provides doctors and healthcare professionals an intuitive way to manage their medical travel businesses and reach patients more effectively. Potential users include hospitals and clinics, individual providers, patient care coordinators, and a marketing partner across 15 countries. Patients are connected to a coordinator, who collects their information and places them with the best provider for their needs. 

The platform earns revenue from every transaction conducted through it and also offers paid marketing services and licensing. Pulse eventually plans to expand its offerings to domestic, government, and insurance medical markets.

Pulse Protocol’s current StartEngine raise has been rated a Neutral Deal by the KingsCrowd investment team.


Pulse is raising funds through sale of common equity at a pre-money valuation of $6.2 million. For a marketplace startup in the medical field, this valuation is fairly reasonable, even at its early stage. However, Pulse’s revenue has been relatively limited so far, resulting in a high revenue multiple. While this valuation isn’t excessive, it is high enough to give Pulse a moderate rating for this metric.


The global medical tourism industry is expected to reach a value of $78.2 billion by 2026, growing at a compound annual growth rate of 18.8% from a 2021 value of $33 billion. While medical tourism wasn’t as severely impacted by the COVID-19 pandemic as traditional tourism, there was some reduction in services — a phenomenon that could account for Pulse’s year-over-year loss of revenue. It should be noted that because the company is not a full provider, Pulse can capture only a limited fraction of the total medical tourism market. Nevertheless, its market rating is above average.


Pulse is headed by a trio of medical tourism experts. CEO Robert Page holds a bachelor of science in developmental economics from Georgetown University and spent a decade and a half in this space before founding Pulse. He first ventured into medical tourism as co-founder and vice president of operations for MedToGo Publishing, which thoroughly researched Mexico’s healthcare system and released a trio of guidebooks on the country’s healthcare system. From there, he helped expand the company into MedToGo International, facilitating patient treatment through a global medical concierge service. After starting and working at Pulse for several years, he led it to a level of success before bringing on his partnering co-founders, both of whom now split their time between Pulse and other engagements.

Co-founder Jonathan Edelheit is a juris doctor from the Villanova University School of Law. After a six-year stint as the vice president of sales and marketing for OptiMed Health Plans, he spent 12 years in editor roles at various healthcare and benefits magazines, work he continues today as editor-in-chief of Corporate Wellness Magazine. He is a founder and chairman of the Medical Tourism Association and Global Healthcare Resources. He and organizations under his leadership have worked to integrate medical tourism into insurance companies’ coverage. These organizations have also assisted South Korea in building up its now highly sought-after medical infrastructure.

Co-founder Renée-Marie Stephano has similarly impressive credentials. Like Edelheit, she holds a JD from Villanova. After several years in private practice, she worked as editor-in-chief for Sustainable Healthcare & Hospital Development Magazine and Medical Tourism Magazine for more than a decade. During that time, she authored several books, co-founded the Healthcare Revolution conference for medical professionals, served as president of the Medical Tourism Association and Corporate Health and Wellness Association, and co-founded Global Healthcare Resources with Edelheit in addition to serving as its CEO. She remains in these three latter leadership roles, serving in a part-time role at Pulse.

While CEO Page has assembled an impressive leadership roster to push Pulse to greater heights (albeit on a largely part-time basis), that roster is somewhat lacking in strong marketing and software development expertise. But the deeply relevant expertise of the team is one of Pulse’s biggest strengths. Overall, Pulse Protocol earns a strong team score.


While Pulse Protocol is solving a challenging problem, it’s not the first to do so. Competitors such as Qunomedical in Germany and Medical Departures in Singapore are also providing patients with medical tourism guidance, and some have been doing it for longer. Pulse is a simple marketplace and lacks patent protection. The software is more of an enabler for the supply side, allowing providers to better market their services to patients, and licensing opportunities allow Pulse to act as a white-label software provider. But the service will become more defensible as it builds out its network of providers and patients. Overall, Pulse has an above-average differentiation score.


Pulse Protocol generated revenue of $48,221 in 2020 — nearly half its 2019 revenue of $90,732. But as Pulse does not provide material goods, only services, these limited profits came at reduced expense to the business. The startup has gotten backing from venture capital firms Amplify, Afore Capital, Kima Ventures and more. Pulse has also seen some limited early traction as it has built out its marketplace with 11 clinics, 21 hospitals, 103 individual providers, nine coordinators, and a marketing partnership. Overall, its performance rating is its highest across all metrics.


Potential investors should first note that Pulse’s two-sided marketplace is a risk. Aiming to serve both medical providers and patients requires twice as much buy-in, which makes such marketplaces difficult to build. In addition, while Pulse emphasizes that its services merely connect patients to medical providers, the business could run into regulatory troubles as it grows. Though countries around the world — including the US — have generally been lax with medical tourism regulations, harsher restrictions could become a future threat.

On the differentiation side, Pulse faces some risk as it has limited means to ensure defensibility. Marketplaces are not difficult to imitate. Finally, even as Pulse’s revenue has remained limited, its finances are of significant concern as the business holds more than $3 million in unexplained short-term debt. That’s a steep climb to wipe the red from Pulse’s ledger.

Bearish Outlook

Dual-sided marketplaces like Pulse Protocol’s are difficult to pull off. Investors should consider not just whether providers will continue to engage with the platform but also whether the business can attract enough patient interest to grow. While government oversight of medical tourism is largely limited to warnings to potential patients, governments could very well impose firm regulatory burdens on the market as a whole, hampering Pulse’s growth potential. Limited avenues to build up Pulse’s defensibility mean the company needs to drastically expand its user base. Therefore, the business faces significant obstacles to profitable growth.

Bullish Outlook

Pulse’s strengths come from its unique emphasis on enabling providers, rather than just patients, to seek out potential leads through marketing and coordination. Existing offerings are largely built to enable medical tourists to seek care on their own. Pulse’s approach could help it pull ahead of its competition. In addition, while there are some expertise gaps among leadership, the team members have long and prestigious careers focused on medical networking. The team’s credibility bolsters Pulse’s chances to succeed.

Executive Summary

Patients’ medical needs are as varied as patients themselves, and they can’t always find proper care in their local communities. Pulse Protocol is building a marketplace for providers around the globe to connect with patients in need, bringing the power of technology and globalization to medical tourism. Led by a trio of founders with plenty of experience in medical tourism, Pulse has generated some traction by building out its medical provider user base.

Despite taking in some revenue, Pulse saw a dramatic decrease from 2019 to 2020, perhaps due to the COVID-19 pandemic’s impact on all global travel. Additionally, its marketplace is not yet large enough to provide defensibility against possible competitors. It also holds a significant and unexplained amount of short-term debt, presenting a financial risk for investors. However, Pulse seems equipped to tackle the challenges of the medical tourism industry. The company’s focus on giving medical providers the tools they need to better market to patients separates it from its competitors. In addition, its founders’ expertise is likely to further boost Pulse to new heights. All in all, Pulse Protocol is a Neutral Deal.

For questions regarding the KingsCrowd staff pick or ratings for this company, please reach out to support@kingscrowd.com.

Analysis written by Benjamin Potts.

Other Deals

UpCounsel on Wefunder 2021

The platform makes it affordable and convenient for small businesses to hire attorneys by eliminating overhead and high hourly rates.…

Valuation Cap: $28,000,000
Min Investment: $250
Industry: Business Services, Software, & Applications
Raised $2,491,361 of $5,000,000 max

Pickzen on Wefunder 2021

The company has developed a no-code platform to make the life of developers easier. The platform can create any type…

Valuation Cap: $8,333,333
Min Investment: $100
Industry: Business Services, Software, & Applications
Raised $115,801 of $750,000 max

SousZen on Wefunder

The web and mobile apps of SousZen, Manager, Expeditor, and Advisor, use next-gen technology to manage inventory, menus, and recipes,…

Valuation Cap: $7,000,000
Min Investment: $100
Industry: Business Services, Software, & Applications
Raised $136,335 of $250,000 max

Create your first portfolio

Create your very own investment portfolio on KingsCrowd.

Now you can track all of your startup investments in one place utilizing our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
Add Pulse Protocol on StartEngine

Follow company

Follow Pulse Protocol on StartEngine